safety of glp 1 receptor agonists Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review GLP-1 agonist efficacy and GLP-1 receptor agonists | How
Description
The comparison between GLP-1RA and SGLT-2 inhibitors shows no difference in their risk for total death (RR = 1.00, 95% CI 0.911.11)
doi: 10.1016/S2213-8587(22)00243-1
doi: 10.1038/ijo.2013.120 94 BodeB
Psychiatry 35, 760768
However, concerns exist regarding the impact of GLP-1 RAs on lean mass, particularly with respect to true skeletal muscle mass
Points represent beta coefficients in Kg and error bars represent the 95% confidence intervals
